Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan, A Retrospective Nhia Database Analysis

Trial Profile

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan, A Retrospective Nhia Database Analysis

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Sunitinib (Primary) ; Pazopanib
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Nov 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 21 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top